Featured News

 

Latest News

Tempus, UPenn Team Up to Improve Leukemia Treatment
Tempus, UPenn Team Up to Improve Leukemia Treatment
News   Apr 28, 2017

Tempus has formed a second collaboration with Penn’s Abramson Cancer Center to improve and personalize treatment for patients diagnosed with acute myeloid leukemia (AML).

READ MORE

Treating Solid Tumors with T-cells
Treating Solid Tumors with T-cells
News   Apr 28, 2017

Researchers have looked at how the signaling molecules of T-cells affect the immediate tumor environment, which includes the connective tissue as well as the blood vessels that supply the tumor.

READ MORE

BioInvent International AB Upgrades its Manufacturing Facility
BioInvent International AB Upgrades its Manufacturing Facility
News   Apr 26, 2017

BioInvent INernational AB expands its manufacturing capability with 3, 50, 200 and 1000 liter bioreactors from Merck.

READ MORE

Propath Receives Queen’s Award for Enterprise
Propath Receives Queen’s Award for Enterprise
News   Apr 26, 2017

Award for international trade recognises outstanding, world-class drug development services.

READ MORE

Enamine, EMBL Partner on Cancer Drug Discovery Research
Enamine, EMBL Partner on Cancer Drug Discovery Research
News   Apr 25, 2017

A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house.

READ MORE

Reversing Gene Damage to Treat Blindness
Reversing Gene Damage to Treat Blindness
News   Apr 24, 2017

n mouse models, advanced gene editing tool reprogrammed photoreceptor rods to mutation-resistant cones.

READ MORE

Malaria Parasite Protein Shows Promise as Cancer Therapeutic
Malaria Parasite Protein Shows Promise as Cancer Therapeutic
News   Apr 21, 2017

A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

READ MORE

How Cancer Evades the Immune System
How Cancer Evades the Immune System
News   Apr 21, 2017

A team of scientists from Singapore has discovered new ways in which cancers can escape the body’s immune system.

READ MORE

Synpromics Raise £5.2m in its Latest Fundraising Round
Synpromics Raise £5.2m in its Latest Fundraising Round
News   Apr 20, 2017

Synpromics, a leading synthetic promoter and gene control company has raised £5.2m in its latest funding round.

READ MORE

Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research
Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research
News   Apr 20, 2017

Prof. Stoll receives the award in support of his research, applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.

READ MORE